Upcoming Conference
Annapolis, MD
The 30th Scientific Conference of the SNIP will be held in May 3-6th, 2026.
Read more.
Past Conference
A Warm Welcome
Following the resounding success of our 29 th SNIP Conference in Omaha, Nebraska (June 7-11, 2025), I am pleased to build on our growth and honored to serve as the Society’s president for 6/2025-5/2026. As one of the original founding members of SNIP, I learned so much and form invaluable collaborations with SNIP members over the years. SNIP has been a transformative influence for my career; therefore, it is only fitting that I repay the society by serving as the current president. Together with an outstanding council and the various committees, we pledge to build our society’s legacy to ensure we hold yet another outstanding annual meeting to develop our mission, our membership and our trainees.
The 29th conference in Omaha, Nebraska, had a record high number of 222 attendees, including members and trainees, and 25 invited non-member speakers. In addition to the outstanding science presented, we provided 22 travel awards for our trainees. With additional funds raised by our Past President, Dr. Gendelman, the attendees were treated to an afternoon fun at the Omaha zoo and dancing with a live band after the banquet. Our upcoming newsletter will provide more details from the conference.
We have a diverse membership comprising preclinical and clinical translational scientists, with interdisciplinary expertise that form the rich and comprehensive symposia at our conferences. I have often heard from our members who remarked at how much they learned at each of our conferences. Furthermore, we put special emphasis on nurturing and supporting our next generation of scientists in our field. Hence, we provide many travel awards to encourage our trainees to attend our annual conferences. These travel awards were at times supported by R13 conference grants from the National Institutes of Health (NIH), especially from NIDA, NIMH and NINDS in the past. We also include in our program special sessions for early career investigator poster and oral presentations; these were always outstanding and extremely well attended.
In addition, we have a new society journal which is led by our Editor-In-Chief, Dr. Howard Gendelman, who has a proven track record of leading our prior associated journal, Journal of NeuroImmune Pharmacology (JNIP), to outstanding impact factors. With the strong membership and the trainees from these laboratories, and the open access to the journal, we have every reason to expect our new journal, Neuroimmune Pharmacology and Therapeutics (NIPT), to exceed the citations of our prior journal. I encourage all of you to continue your support for this journal by submitting your best work to the journal.
On behalf of our society and our Council, we look forward to seeing you in Annapolis, Maryland for our 30 th annual SNIP conference on May 3-6, 2026!
— Linda Chang, MD, MS,
President
Newsletter
An Official Newsletter from the Society on NeuroImmune Pharmacology.
© 2001-2025 Society on NeuroImmune Pharmacology